BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 billion doses

Pfizer previously said the partners would likely produce between 2.3 billion and 2.4 billion doses in 2021. BioNTech cited its new facility in the German city of Marburg and an expansion of the pair's network of third-party manufacturers and suppliers as drivers of the larger volumes.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news